Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy.
Saved in:
| Title: | Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy. |
|---|---|
| Authors: | Mıldanoğlu, Maral Martin1 (AUTHOR) mmildanoglu@gmail.com, Kemik, Fatih2 (AUTHOR), Eryaşar, Melisa1 (AUTHOR), Özçelik, Hakan1,2 (AUTHOR), Sünger, Erdem1 (AUTHOR), Yücel, Mehmet Haluk1 (AUTHOR), Engin Delipoyraz, Ebru1 (AUTHOR), Fidan, Sena1 (AUTHOR), Muğlu, Harun1 (AUTHOR), Çakan Demirel, Burçin1 (AUTHOR), Hamdard, Jamshid1 (AUTHOR), Kutlu, Yasin1 (AUTHOR), Açıkgöz, Özgür1 (AUTHOR), Selcukbiricik, Fatih2 (AUTHOR), Şeker, Mesut1 (AUTHOR), Bilici, Ahmet1 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). Apr2026, Vol. 19 Issue 4, p587. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14248247 |
|---|---|
| DOI: | 10.3390/ph19040587 |
